| Literature DB >> 25591908 |
Silvia R Terra1, João Carlos R Cardoso2, Rute C Félix2, Leo Anderson M Martins1, Diogo Onofre G Souza1, Fatima C R Guma1, Adelino Vicente M Canário2, Vanessa Schein3.
Abstract
Stanniocalcin 1 (STC1) and calcitonin gene-related peptide (CGRP) are involved in bone formation/remodeling. Here we investigate the effects of STC1 on functional heterodimer complex CALCRL/RAMP1, expression and activity during osteoblastogenesis. STC1 did not modify CALCRL and ramp1 gene expression during osteoblastogenesis when compared to controls. However, plasma membrane spatial distribution of CALCRL/RAMP1 was modified in 7-day pre-osteoblasts exposed to either CGRP or STC1, and both peptides induced CALCRL and RAMP1 assembly. CGRP, but not STC1 stimulated cAMP accumulation in 7-day osteoblasts and in CALCRL/RAMP1 transfected HEK293 cells. Furthermore, STC1 inhibited forskolin stimulated cAMP accumulation of HEK293 cells, but not in CALCRL/RAMP1 transfected HEK293 cells. However, STC1 inhibited cAMP accumulation in calcitonin receptor (CTR) HEK293 transfected cells stimulated by calcitonin. In conclusion, STC1 signals through inhibitory G-protein modulates CGRP receptor spatial localization during osteoblastogenesis and may function as a regulatory factor interacting with calcitonin peptide members during bone formation.Entities:
Keywords: Calcitonin gene-related peptide; Calcitonin gene-related peptide receptor; Osteoblastogenesis; Stanniocalcin 1; cAMP
Mesh:
Substances:
Year: 2015 PMID: 25591908 DOI: 10.1016/j.mce.2015.01.010
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102